dc.contributor.advisor | Alguiar Bernaola, Luz Rocio | es_PE |
dc.contributor.author | Cruz Escate, Jose Carlos | es_PE |
dc.contributor.author | Hernández Becerra, Karin Mardely | |
dc.date.accessioned | 2025-03-06T21:00:55Z | |
dc.date.available | 2025-03-06T21:00:55Z | |
dc.date.issued | 2025-02-25 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12970/2538 | |
dc.description.abstract | Objetivo: evaluar y sintetizar la evidencia disponible sobre los efectos secundarios del Levonorgestrel y el nivel de conocimiento sobre su uso en la población femenina durante la última década. Material y método: se realizó una revisión de la literatura científica utilizando bases de datos como PubMed, Scielo, Elsevier y repositorios universitarios. Se identificaron 1,693 estudios, de los cuales se seleccionaron 42 que cumplían con los criterios de inclusión. Se analizaron los efectos secundarios reportados y el nivel de conocimiento de las usuarias.
Resultados: los efectos secundarios más comunes incluyen dolores de cabeza, náuseas y sensibilidad mamaria. También se documentaron eventos adversos graves como embarazos ectópicos. Se encontró que el nivel de conocimiento sobre el Levonorgestrel varía significativamente: el 42.9% de las tesis revisadas reportan un nivel medio de conocimiento, el 35.7% alto, y el 21.4% bajo.
Conclusiones: hay un aumento en las publicaciones sobre los efectos adversos del Levonorgestrel, indicando una mayor preocupación científica. Se sugiere la necesidad de mejorar la educación y el asesoramiento sobre el uso de este anticonceptivo. Se recomienda fortalecer la educación, capacitar a profesionales de salud, implementar monitoreo continuo y desarrollar políticas de
salud reproductiva. | es_PE |
dc.description.abstract | Objective: to evaluate and synthesize the available evidence on the side effects of Levonorgestrel and the level of knowledge about its use in the female population during the last decade..
Method: a review of the scientific literature was carried out using databases such as PubMed, Scielo, Elsevier and university repositories. A total of 723 studies were identified, from which 42 were selected that met the inclusion criteria. The reported side effects and the level of knowledge of the users were analyzed.
Results: the most common side effects included headaches, nausea and breast tenderness. Serious adverse events such as ectopic pregnancy were also documented. The level of knowledge about Levonorgestrel was found to vary significantly: 42.9% of the
reviewed theses report a medium level of knowledge, 35.7% high, and 21.4% low. Conclusions: there is an increase in publications on the adverse effects of Levonorgestrel, indicating increased scientific concern. The variability in knowledge suggests the need to improve
education and counseling on the use of this contraceptive. It is recommended to strengthen education, train health professionals, implement continuous monitoring, encourage research, and develop evidence-based reproductive health policies. | es_PE |
dc.format | application/pdf | es_PE |
dc.language.iso | spa | es_PE |
dc.publisher | Universidad María Auxiliadora | es_PE |
dc.rights | info:eu-repo/semantics/openAccess | es_PE |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | es_PE |
dc.subject | Levonorgestrel | es_PE |
dc.subject | Efectos secundarios | es_PE |
dc.subject | Anticonceptivo de emergencia | es_PE |
dc.subject | Salud reproductiva | es_PE |
dc.subject | Eventos adversos | es_PE |
dc.subject | Educación sexual | es_PE |
dc.subject | Side effects | es_PE |
dc.subject | Emergency contraceptive | es_PE |
dc.subject | Knowledge | es_PE |
dc.subject | Reproductive health | es_PE |
dc.subject | Reproductive health | es_PE |
dc.subject | Adverse events | es_PE |
dc.subject | Sexual education | es_PE |
dc.title | Efectos secundarios de levonorgestrel: revisión sistemática de enero 2014 - diciembre 2023 | es_PE |
dc.title.alternative | Side effects of levonorgestrel: systematic review january 2014 - december 2023 | es_PE |
dc.type | info:eu-repo/semantics/bachelorThesis | es_PE |
dc.publisher.country | PE | es_PE |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.01.05 | es_PE |
dc.type.version | info:eu-repo/semantics/acceptedVersion | es_PE |
thesis.degree.discipline | Farmacia y Bioquímica | es_PE |
thesis.degree.grantor | Universidad María Auxiliadora. Facultad de Farmacia y Bioquímica. | es_PE |
thesis.degree.name | Químico Farmacéutico | es_PE |
renati.advisor.dni | 09578116 | |
renati.advisor.orcid | https://orcid.org/0009-0008-8556-2585 | es_PE |
renati.author.dni | 42077566 | |
renati.author.dni | 47825715 | |
renati.discipline | 917046 | es_PE |
renati.juror | Córdova Serrano, Gerson | es_PE |
renati.juror | La Serna La Rosa, Pablo Antonio | es_PE |
renati.juror | Dionicio Escalante, Elisa Roxana | es_PE |
renati.level | https://purl.org/pe-repo/renati/level#tituloProfesional | es_PE |
renati.type | https://purl.org/pe-repo/renati/type#tesis | es_PE |